PTC Therapeutics GAAP EPS of -$1.78 misses by $0.27, revenue of $149M beats by $2.1M

May 03, 2022 4:05 PM ETPTC Therapeutics, Inc. (PTCT)By: Manshi Mamtora, CFA
  • PTC Therapeutics press release (NASDAQ:PTCT): Q1 GAAP EPS of -$1.78 misses by $0.27.
  • Revenue of $149M (+26.3% Y/Y) beats by $2.1M.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.